期刊文献+

二十二碳六烯酸增加大鼠冠状动脉平滑肌细胞大电导钙离子激活钾离子流的机制 被引量:11

Mechanism related to docosahexaenoic acid induced large conductance calcium-activated potassium channel currents increase in coronary smooth muscle cells
原文传递
导出
摘要 目的 探讨二十二碳六烯酸(DHA)增加冠状动脉平滑肌细胞(SMC)大电导钙离子激活钾离子流(BK)的机制.方法酶消化法分离正常大鼠冠状动脉SMC.采用不同钾通道阻滞剂,对冠状动脉SMC的钾离子通道进行鉴定.采用全细胞膜片钳实验技术研究DHA及其代谢产物16,17-环氧二十二碳五烯酸(16,17-EDP)对冠状动脉平滑肌细胞BK通道的影响,并观察加入细胞色素P450环氧化酶抑制剂SKF525A孵育SMC后BK通道电流的变化.结果正常冠状动脉平滑肌细胞BK通道电流约占总钾离子流的(64.2±2.7)%(n=20).DHA可激活BK通道,半效浓度为(0.23±0.03)μmoL/L,但当使用细胞色素P450环氧化酶抑制剂SKF525A预孵育SMC后,DHA对BK通道的激活作用消失,而DHA代谢产物16,17-EDP可产生与DHA相同的BK通道激活作用,半效浓度为(19.7±2.8)nmol/L.结论 DHA通过细胞色素P450环氧化酶代谢途径激活平滑肌细胞BK通道,从而扩张冠状动脉. Objective To investigate the mechanism of enhanced large conductance calciumactivated potassium channel currents (BK) in coronary smooth muscle cells (SMCs) by docosahexaenoic acid (DHA). Methods Coronary SMCs were isolated by enzyme digestion. Potassium channels in coronary SMCs were identified by applications of different potassium blockers. Effects of DHA and its metabolite 16,17-epoxydocosapentaenoic acid (16,17-EDP) on BK channels in the absence and presence of cytochrome P450 epoxygenase inhibitor SKF525A were studied by patch clamp in whole-cell configuration. Results BK channels were widely distributed in SMCs, and BK currents in normal SMCs accounted for (64.2±2.7)%of total potassium currents(n =20). DHA could activate BK channels, and its 50% effective concentration (EC50) was (0.23±0.03)μmol/L, however, the effect of DHA on BK channels was abolished after SMCs were incubated with cytochrome P450 epoxygenase inhibitor SKF525A. 16,17-EDP, a metabolite of DHA, could reproduce the effects of DHA on BK channels, and its EC50 was (19.7± 2.8) nmol/L.Conclusion DHA and metabolites can activate BK channels and dilate coronary arteries through activating cytochrome P450 epoxygenase pathway.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2011年第4期348-352,共5页 Chinese Journal of Cardiology
基金 基金项目:国家自然科学基金面上项目(81070157)
关键词 冠状血管 肌细胞 平滑肌 二十二碳六烯酸类 大电导钙激活钾通道 Coronary vessels Myocytes, smooth muscle Docosahexaenoic acids Largeconductance calcium-activated potassium channels
  • 相关文献

参考文献3

二级参考文献23

  • 1周琳,蒋彬,李红霞,陈弹,程绪杰,蒋文平.胺碘酮对大鼠肥厚心肌细胞急性电生理作用的研究[J].中华心血管病杂志,2006,34(2):164-168. 被引量:27
  • 2王如兴,蒋文平.正常耐钙Spraque-Dawley大鼠心室肌细胞分离方法及体会[J].中国心脏起搏与心电生理杂志,2007,21(1):59-62. 被引量:17
  • 3Alberto A, Stevo J, Sverre K, et al. Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine : an analysis of findings from the VALUE trial Journal of Hypertension, 2006, 24:2163-2168.
  • 4Sever PS, Poulter NR, Elliott WJ, et al. Blood pressure reduction is not the only determinant of outcome. Circulation, 2006, 113 : 2754 -2774.
  • 5Formica RN, Friedman AL, Lorber MI, et al. A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period. Nephrology Dialysis Transplantation, 2006, 21 : 1389-1394.
  • 6Bojarski J. Stereoselective chromatography of cardiovascular drugs : an update. J Biochem Biophys Methods, 2002, 54: 197-220.
  • 7Luksa J, Josic D, Kremser M, et al. Pharmacokinetic behaviour of R-( + )-and S-( - ) -amlodipine after single enantiomer administration. J Chromatogr B Biomed Sci Appl, 1997, 703: 185-193.
  • 8Catterall WA, Striessnig J. Receptor sites for Ca^2 + channel antagonists. Trends Pharmacol Sci, 1992, 13:256-262.
  • 9Mitterdorfer J, Grabner M, Kraus RL, et al. Molecular basis of drug interaction with L-type Ca^2 + channels. J Bioenerg Biomembr, 1998, 30:319-334.
  • 10Striessnig J, Grabner M, Mitterdorfer J, et al. Structural basis of drug binding to L Ca^2+ channels. Trends Pharmacol Sci, 1998, 19: 108-115.

共引文献16

同被引文献106

  • 1周华,宋洁,胡金兰,马嵘,孔德虎.平滑肌细胞上的钙库操纵性通道[J].生理科学进展,2005,36(4):369-371. 被引量:19
  • 2中国心脏调查组,胡大一,潘长玉.中国住院冠心病患者糖代谢异常研究——中国心脏调查[J].中华内分泌代谢杂志,2006,22(1):7-10. 被引量:470
  • 3王顺,马爱群,宋少武,权青海,郑晓晖,赵新锋.短期补充鱼油对超重高血压患者大动脉弹性的改善作用[J].中国循环杂志,2007,22(1):24-27. 被引量:6
  • 4Lavie C J, Milani RV, Mehra MR, et al. Omega-3 polyunsaturated fatty acids and cardiovascular diseases [ J ]. J Am Coll Cardiol, 2009, 54(7) :585.
  • 5Lee JH, O'Keefe JH, Lavie CJ, et al. Omega-3 fatty acids: cardio- vascular benefits, sources and sustainability [ J ]. Nat Rev Cardiol, 2009, 6(12) :753.
  • 6Wang RX, Chai Q, Lu T, et al. Activation of vascular BK channels by docosahexaenoic acid is dependent on cytochrome P450 epoxyge- nase activity [ J]. Cardiovasc Res, 2011, 90(2) :344.
  • 7Ye D, Zhang D, Oltman C, et al. Cytoehromep-450 epoxygenase metabolites of docosahexaenoate potently dilate coronary arterioles by activating large-conductance calcium-activated potassium channels [J]. J Pharmacol Exp Ther, 2002, 303(2) :768.
  • 8Li X, Hong S, Li PL, et al. Docosahexanoic acid-induced coronary arterial dilation: actions of 17S-hydroxy docosahexanoic acid on K channel activity [J]. J Pharmacol Exp Ther, 2011, 336(3) :891.
  • 9Lauterbach B, Barbosa-Sicard E, Wang MH, et al. Cytochrome P450-dependent eicosapentaenoic acid metabolites are novel BK channel activators [ J ]. Hypertension, 2002, 39 (2 Pt 2) :609.
  • 10Zhang Y, Ohman CL, Lu T, et al. EET homologs potently dilatecoronary microvessels and activate BKc channels [ J]. Am J Physiol Heart Circ Physiol, 2001, 280 ( 6 ) : H2430.

引证文献11

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部